V

Verano Holdings Corp
CNSX:VRNO

Watchlist Manager
Verano Holdings Corp
CNSX:VRNO
Watchlist
Price: 5.01 CAD -10.22% Market Closed
Updated: Jun 2, 2024
Section:
 

Relative Value

The Relative Value of one VRNO stock under the Base Case scenario is hidden CAD. Compared to the current market price of 5.01 CAD, Verano Holdings Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VRNO Relative Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Multiples

1.4
P/S
P/S
Price to Sales
1.4
vs History
63
vs Industry
64
Median 3Y
1.4
Median 5Y
1.4
Industry
2.4
Forward
1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-4.6
Median 5Y
-4.5
Industry
22.4
Forward
-28.3
More Details
13.8
P/OCF
P/OCF
Price to OCF
13.8
vs History
56
vs Industry
29
Median 3Y
14.1
Median 5Y
14.1
Industry
16.9
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
6.5
Median 5Y
6.5
Industry
22.6
More Details
1
P/B
P/B
Price to Book Value
1
vs History
70
vs Industry
63
Median 3Y
1.2
Median 5Y
1.2
Industry
2
More Details
1.7
EV/S
EV/S
Enterprise Value to Sales
1.7
vs History
56
vs Industry
58
Median 3Y
1.7
Median 5Y
1.7
Industry
2.5
Forward
1.2
More Details
3.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.5
vs History
58
vs Industry
55
Median 3Y
3.5
Median 5Y
3.5
Industry
5.1
More Details
5.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
5.6
vs History
68
vs Industry
44
Median 3Y
6.4
Median 5Y
6.3
Industry
13.3
More Details
12.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
12.6
vs History
60
vs Industry
33
Median 3Y
14
Median 5Y
12.9
Industry
16.6
More Details
17
EV/OCF
EV/OCF
Enterprise Value to OCF
17
vs History
58
vs Industry
26
Median 3Y
17.3
Median 5Y
17.3
Industry
15.7
More Details
36.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
36.6
vs History
48
vs Industry
13
Median 3Y
36.5
Median 5Y
36.5
Industry
17.7
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
70
vs Industry
68
Median 3Y
0.8
Median 5Y
0.8
Industry
1.9
More Details

Multiples Across Competitors

VRNO Competitors Multiples
Verano Holdings Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Verano Holdings Corp
CNSX:VRNO
1.7B CAD 1.4 -4.5 5.6 12.6
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
779.7B USD 21.7 127 62.1 70.7
DK
Novo Nordisk A/S
CSE:NOVO B
4.1T DKK 16.9 46.3 34.5 37.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
353B USD 4.1 9.2 11.3 14.8
US
Merck & Co Inc
NYSE:MRK
318B USD 5.2 137.9 34.4 56.2
UK
AstraZeneca PLC
LSE:AZN
189B GBP 5.1 38 174.7 278.7
CH
Roche Holding AG
SIX:ROG
184.2B CHF 3.1 16 9.1 10.8
CH
Novartis AG
SIX:NOVN
182.3B CHF 3.4 11.5 8.8 12.8
US
Pfizer Inc
NYSE:PFE
162.4B USD 2.9 -525.6 12.7 20.6
P/E Multiple
Earnings Growth
US
V
Verano Holdings Corp
CNSX:VRNO
Average P/E: 55.1
Negative Multiple: -4.5 		N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
127
364%
DK
Novo Nordisk A/S
CSE:NOVO B
46.3
83%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
9.2
-21%
US
Merck & Co Inc
NYSE:MRK
137.9
7 598%
UK
AstraZeneca PLC
LSE:AZN
38
175%
CH
Roche Holding AG
SIX:ROG
16
28%
CH
Novartis AG
SIX:NOVN
11.5
17%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -525.6
683%

See Also

Summary
VRNO intrinsic value, competitors valuation, and company profile.
DCF Valuation
VRNO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VRNO stock valuation using valuation multiples.
Wall Street Estimates
VRNO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VRNO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 143,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.